The Laboratory for Cell Analysis (LCA) is a core facility that provides support to the UCSF Comprehensive Cancer Center. The LCA provides: ? Flow and image cytometers and the technical support needed to make use of these instruments. ? Education for UCSF students, staff and faculty in cytometry technology and applications. ? Expertise for the development of new cytometric assays. Instruments currently available to Cancer Center Members include: a Becton-Dickinson (BD) FACSVantage SE sorter with high-speed cell sorting, three laser excitation, ten detectors, and single-cell cloning; two BD FACSAria Digital cell sorters, three laser excitation, 15 detectors; four BD FACSCalibur flow cytometers with dual lasers capable of four-color analysis, automated sample loading and sorting options; fourZeiss Confocal Laser Scanning Microscopes, three with multiphoton lasers, two with spectral emission detection and live cell scanning capability; two digital video fluorescent microscopes; and two fluorescent microscopes with high-resolution CCD cameras; a Cellomics ArrayScan HCS automated fluorescence microscopic imaging system for high-content screening and high-content analysis; and a Leica Laser Micro Dissection microscope consisting of an automated upright microscope with a three-dimensional optical control of the dissection laser beam which uses noncontact sample collection by gravity. A variety of computer software packages.and platforms are available to collect and analyze data. In addition, the staff of the LCA offers its expertise in the use of this technology as it applies to instrument support and biological applications to Cancer Center Members. The LCA Web site is http://cancer.ucsf.edu/lca/index.php.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082103-10
Application #
7619933
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
10
Fiscal Year
2008
Total Cost
$321,386
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Brunner, Katja; John, Constance M; Phillips, Nancy J et al. (2018) Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence. J Lipid Res 59:1893-1905
Felix, Janine F; Joubert, Bonnie R; Baccarelli, Andrea A et al. (2018) Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol 47:22-23u
Cobler, Lara; Zhang, Hui; Suri, Poojan et al. (2018) xCT inhibition sensitizes tumors to ?-radiation via glutathione reduction. Oncotarget 9:32280-32297
Li, Megan; Mulkey, Flora; Jiang, Chen et al. (2018) Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res 24:4734-4744
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19:1212-1223
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28
Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSUREā„¢). Prostate 78:32-39
Guydish, Joseph; Tajima, Barbara; Le, Thao et al. (2018) Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control 27:43-49
Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot et al. (2018) Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer 65:e27034
Fan, Qi Wen; Nicolaides, Theodore P; Weiss, William A (2018) Inhibiting 4EBP1 in Glioblastoma. Clin Cancer Res 24:14-21

Showing the most recent 10 out of 192 publications